CIK 0001267565 · Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-18 | Freund John Gordon Director | Sale | −20 | $34.05 | $681 | 83,952 |
| 2026-05-15 | Freund John Gordon Director | Sale | −4,127 | $34.54 | $143K | 83,972 |
| 2026-05-13 | Lurker Nancy Director | Sale | −4,500 | $35.97 | $162K | 18,017 |
| 2026-05-11 | BOHLIN GAREN G Director | Sale | −8,700 | $37.18 | $323K | 62,259 |
| 2026-03-18 | Dieter David EVP & General Counsel | Sale 10b5-1 | −13,976 | $34.92 | $488K | 77,071 |
| 2026-03-09 | Dieter David EVP & General Counsel | Sale 10b5-1 | −6,224 | $36.65 | $228K | 91,047 |
| 2026-03-03 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −46,417 | $40.36 | $1.9M | 75,329 |
| 2026-03-03 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −3,559 | $40.99 | $146K | 71,770 |
| 2025-12-08 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −11,125 | $47.89 | $533K | 110,088 |
| 2025-12-08 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −6,475 | $48.66 | $315K | 103,613 |
| 2025-12-05 | Balice-Gordon Rita J. Director | Sale | −3,650 | $47.03 | $172K | 52,629 |
| 2025-11-12 | Fallon John A. Director | Sale | −34,853 | $47.21 | $1.6M | 64,634 |
| 2025-11-06 | Tupper Colleen EVP & Chief Financial Officer | Sale 10b5-1 | −25,142 | $40.38 | $1.0M | 131,525 |
| 2025-11-06 | Tupper Colleen EVP & Chief Financial Officer | Sale 10b5-1 | −4,858 | $41.28 | $201K | 126,667 |
| 2025-08-29 | Smith Thomas B EVP and Chief Medical Officer | Sale | −17,478 | $38.42 | $672K | 70,264 |
| 2025-08-18 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −16,389 | $38.21 | $626K | 103,613 |
| 2025-08-15 | SANTINI GINO Director | Sale | −5,405 | $37.19 | $201K | 95,042 |
| 2025-08-13 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −4,861 | $38.03 | $185K | 103,613 |
| 2025-08-13 | Rubric Capital Management LP 10% owner | Sale | −25,000 | $37.85 | $946K | 3,132,743 |
| 2025-08-08 | Freund John Gordon Director | Sale | −11,659 | $34.36 | $401K | 23,129 |
Page 1 of 7 · 130 trades